Skip to main content
. 2021 Nov 2;8:764701. doi: 10.3389/fvets.2021.764701

Table 4.

Antimicrobial resistance rates (%) according to antimicrobial, sampling point (B, BRANDING; I, WEANING/INDUCTION; R, REPROCESSING), and bacteria species.

Class Antimicrobial Mannheimia haemolytica Histophilus somni
B I R B I R
n = 1 n = 30 n = 27 n = 0 n = 10 n = 20
Aminocyclitol Spectinomycin 0 20 3.7 1 10 0
Cephalosporin Ceftiofur 0 0 0 0 0
Fluoroquinolone Danofloxacin 0 3.3 0 10 5
Enrofloxacin 0 0 0 10 0
Macrolide Tilmicosin 0 13.3 14.8 10 0
Tulathromycin 0 0 3.7 0 0
Penicillin Penicillin 0 3.3 14.8 0 0
Phenicol Florfenicol 0 0 0 10 0
Tetracycline Oxytetracycline 0 0 7.4 0 5
Antimicrobial Antimicrobial Pasteurella multocida Mycoplasma bovis
B I R B I R
n = 24 n = 88 n = 38 n = 2 n = 19 n = 28
Aminocyclitol Spectinomycin 8.3 10.2 15.8
Cephalosporin Ceftiofur 0 0 0
Fluoroquinolone Danofloxacin 0 0 0
Enrofloxacin 0 0 0 0 0 0
Macrolide Gamithromycin 0 1.1 5.3 100 84.2 100
Tildipirosin 0 0 5.3 100 94.7 100
Tilmicosin 4.2 3.4 7.9 100 94.7 100
Tulathromycin 0 0 5.3 100 31.6 60.7
Tylosin 100 78.9 85.7
Penicillin Penicillin 0 0 0
Phenicol Florfenicol 0 0 0 50 36.8a 67.9b
Tetracycline Chlortetracycline 0 15.8 14.3
Oxytetracycline 0 15.8 21.4
Tetracycline 8.3 9.1 15.8
1

A dash (–) denotes either absence of clinical breakpoints for that specific pathogen–antimicrobial combination or absence of tested isolates.

a,b

Within row percentages followed by different letters denote statistically significant differences between resistance rates for each species (p < 0.05).